Breaks Categories: News

ThursdayFeb 04, 2021 11:16 am

BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it joins with millions of healthcare advocates around the world in support of World Cancer Day. The designation seeks to raise awareness, elevate public understanding of the global cancer burden, promote greater equity and ensure that cancer control continues to be a priority in the world health and development agenda. “At Genprex, our primary focus is on the patients and communities we serve. Toward that end, we are relentless in our pursuit to bring innovative and life-saving oncology treatments to patients suffering with…

Continue Reading

ThursdayFeb 04, 2021 9:16 am

BioMedNewsBreaks – Capricor Therapeutics Inc. (NASDAQ: CAPR) Featured by M-Vest

Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company, was recently highlighted as a featured company by M-Vest. The business description reads, “CAP-1002 consists of allogeneic cardiosphere-derived cells, or CDCs, a unique population of cells that have been shown to exert potent immunomodulatory activity, which alters the immune system’s activity to stimulate cellular regeneration. CDCs have been the subject of over 100 peer-reviewed scientific publications and have been administered to approximately 200 human subjects across several clinical trials.” For more details, visit https://ibn.fm/Ejtce About Capricor Therapeutics Inc. Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization…

Continue Reading

TuesdayFeb 02, 2021 1:44 pm

BioMedNewsBreaks – Predictive Oncology (NASDAQ: POAI) Ranked as Buy in Litchfield Hills Recent Analyst Report

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has been rated as a “Buy” in the first analyst coverage report released by equity research firm Litchfield Hills Research LLC. POAI was listed as a “Buy” under the report’s three-tiered (buy, hold, sell) rating system. Litchfield Hills Research strictly follows FINRA standards for quality and objectivity, and the research firm has certified that the publication is compliant with FINRA research rules 2241, 3110. In addition, Litchfield confirmed that the report has been reviewed by a supervisory senior analyst and is…

Continue Reading

TuesdayFeb 02, 2021 10:49 am

BioMedNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Trio of Upcoming Investment, Industry Events

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, is involved in several upcoming investment and industry conferences, and has released information regarding three upcoming investment and industry conferences in which it will be participating. The events include CSE Tech Tuesdays, a virtual public company showcase, which is today at 4:15 p.m. ET; World Agri-Tech Innovation Summit, a virtual innovation event slated for March 9–10; and the Banff Capital Conference, scheduled for March 12–14. The company noted that these events are part of MustGrow’s awareness initiatives. The…

Continue Reading

TuesdayFeb 02, 2021 10:38 am

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Marketing VP Authors Article on Increasing Need for Disposable Technologies

Brain Scientific (OTCQB: BRSF) vice president of marketing Stuart Bernstein has authored a DotMed Healthcare Business News article titled “COVID’s influence on neurology drives need for disposable technologies.” In the article, Bernstein notes both time management and infection control as key factors in the growing need for disposable technologies. The article states that headsets with pre-gelled and fixed electrodes could reduce the time-consuming electrode placement process. In addition, the article explains that commercially available EEG headsets that pair with encephalographs and amplifiers of EEG signals can deliver results in an average of 20 minutes. These time-saving measures mean that doctors could…

Continue Reading

TuesdayFeb 02, 2021 10:26 am

BioMedNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, has announced that it will postpone its upcoming virtual road show. Trxade had previously announced that the road show event would be held Wednesday, Feb. 3, 2021, at 11 a.m. ET. The company, which operates across the United States in all 50 states, will reschedule the event and announce the new date and time. Trxade Group is committed to its mission of making healthcare services affordable and accessible. “The virtual roadshow will be postponed to a later date, which will be announced via press release accompanied by a webcast link…

Continue Reading

MondayFeb 01, 2021 3:23 pm

BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Issues Shareholder Letter, Corporate Update

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has issued a shareholder letter and corporate update outlining its developments and initiatives for 2020 and anticipated milestones for 2021 and beyond. “We achieved many significant milestones in 2020 that have set the stage for a transformational 2021,” stated Rodney Varner, president and CEO of Genprex. “The primary focus this past year was on the preparation for our two lead clinical trials in non-small cell lung cancer (‘NSCLC’). Our Acclaim-1 clinical trial will combine REQORSA with Tagrisso(R) for patients with late stage NSCLC whose disease progressed…

Continue Reading

MondayFeb 01, 2021 12:30 pm

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Featured in Med-Tech Innovation Article

Brain Scientific (OTCQB: BRSF), a neurology focused device and software company, was featured in a recent Med-Tech Innovation article titled, “The need for neurological disposable tech amid the COVID-19 pandemic.” In the piece, Brain Scientific’s VP of Marketing, Stuart Bernstein, examines the need of neurological disposable technology following the effects of COVID0-19.  “The solution is clear and has come in the form of disposable EEG headsets,” Bernstein writes. “These devices can be quickly integrated into the current, standard medical processes for COVID-19 patients, and those without COVID-19, in need of a brain scan to swiftly acquire, record, transmit and display…

Continue Reading

ThursdayJan 28, 2021 2:04 pm

BioMedNewsBreaks – Clearside Biomedical Inc. (NASDAQ: CLSD) Closes Sale of Common Stock for $12M

Clearside Biomedical (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that it has closed the sale of 4,209,050 shares of common stock. The shares were priced at $2.851 per share, with the sale resulting in approximately $12 million. In the announcement, Clearside noted that the sale took place with institutional investors and certain existing stockholders. Clearside is recognized for its proprietary SCS Microinjector(R), designed to combat sight-threatening disease. The SCS Microinjector targets the suprachoroidal space (“SCS”) and provides access to the macula,…

Continue Reading

ThursdayJan 28, 2021 1:01 pm

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Featured in BioWorld MedTech Article

Brain Scientific (OTCQB: BRSF), a neurology focused device and software company, was featured in a recent BioWorld MedTech article titled, “Brain Scientific begins development of E-Tattoo device for continuous brain monitoring.” The piece covers Brain Scientific’s efforts to combine a miniaturized electroencephalogram (“EEG”) with subcutaneous graphene electrodes to produce a minimally invasive brain monitoring device that could provide continuous data on patients with neurological conditions. The New York-based company’s device, called the Brain E-Tattoo, would monitor brain wave activity outside the clinical setting and enable long-term continuous data collection without interrupting daily life. To view the full article, visit https://ibn.fm/E85u7…

Continue Reading